Cargando…
Human neutralizing mAbs against Middle East respiratory syndrome coronavirus (MERS-CoV)
Human neutralizing mAbs against MERS-CoV could aid the development of new therapeutics to treat or prevent infection.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149073/ http://dx.doi.org/10.1038/scibx.2014.629 |
Ejemplares similares
-
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS – MERS, MERS CoV
Publicado: (2017) -
Middle East respiratory syndrome coronavirus (MERS-CoV)
Publicado: (2019) -
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Publicado: (2014) -
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets
por: de Wit, Emmie, et al.
Publicado: (2018) -
Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)
por: Bleibtreu, A., et al.
Publicado: (2020)